Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares OutstandingShares Outstanding
Ratios

Acro Biomedical (ACBM) Receivables - Other (2019)

Acro Biomedical has reported Receivables - Other over the past 1 years, most recently at $45000.0 for Q3 2019.

  • Quarterly results put Receivables - Other at $45000.0 for Q3 2019, changed N/A from a year ago — trailing twelve months through Sep 2019 was $45000.0 (changed N/A YoY), and the annual figure for FY2019 was $45000.0, changed.
  • Receivables - Other for Q3 2019 was $45000.0 at Acro Biomedical, up from $20000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for ACBM hit a ceiling of $45000.0 in Q3 2019 and a floor of $20000.0 in Q2 2019.